Search this site:

Vol. 27, No. 5
May 2004

Editorials

Quiet! Hospital Zone

C. R. Conti, M.D., M.A.C.C. 251

Special Article

Reperfusion Therapy for Acute Myocardial Infarction: Drugs or Devices? Is This the Right Question?

G. S. Pavlides, M.D., D. V. Cokkinos, M.D. 254

Review

Lipoprotein(a): New Insights into Mechanisms of Atherogenesis and Thrombosis

A. Deb, M.D., and N. M. Caplice, M.D., Ph.D. 258

Clinical Investigations

Importance of a History of Hypertension for the Prognosis after Acute Myocardial InfarctionÑfor the Bucindolol Evaluation in Acute Myocardial Infarction Trial (BEAT) Study Group

I. Ali, M.D., D. Akman, M.D., N. Eske Bruun, M.D., L. Køber, M.D., B. Brendorp, M.D., M. Ottesen, M.D., J. Møller, M.D., C. Torp-Pedersen, M.D. 265

Reduced Quality of Life after Myocardial Infarction in Women Compared with Men

S. Agewall, M.D., Ph.D., FESC, M. Berglund, R.N., L. Henareh, M.D. 271

Ethnic Differences in Utilization of Invasive Cardiac Procedures and in Long-Term Survival Following Acute Myocardial Infarction

K.-H. Mak, M.D., FACC, J. D. Kark, M.D., Ph.D., K.-S. Chia, M.D., C. Tan, B.A., B.-H. Foong, B.A., S.-K. Chew, mbbs, m.sc. (Epidemiology) (London) 275

Plasma Vascular Endothelial Growth Factor Level Is Elevated in Patients with Multivessel Coronary Artery Disease

K. Nakajima, M.D., S. Tabata, M.D., T. Yamashita, M.D., M. Kusuhara, M.D., K. Arakawa, M.D., R. Ohmori, Ph.D., A. Yonemura, M.D., K. Higashi, M.D., M. Ayaori, M.D., H. Nakamura, M.D., F. Ohsuzu, M.D. 281

Gender-Specific Association between Preproendothelin-1 Genotype and Reduction of Systolic Blood Pressure during Antihypertensive Treatment - Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation
versus Atenolol (SILVHIA)

P. Hallberg, M.D., J. Karlsson, L. Lind, M.D., Ph.D., K. Michaëlsson, M.D., Ph.D., L. Kurland, M.D., Ph.D., T. Kahan, M.D., Ph.D., K. Malmqvist, M.D., Ph.D., K. P. Öhman, M.D., Ph.D., F. Nyström, M.D., Ph.D., U. Liljedahl, A.C. Syvänen, Ph.D., H. Melhus, M.D., Ph.D. 287

The Importance of Gender on Coronary Artery Size: In-Vivo Assessment by Intravascular Ultrasound

S.-G. Kim, M.D., S. Apple, dnsc, R.N., G. S. Mintz, M.D., T. McMillan, mph, D. A. Caños, MPH, A. Maehara, M.D., N. J. Weissman, M.D. 291

Coenzyme Q10 in Patients with End-Stage Heart Failure Awaiting Cardiac Transplantation: A Randomized, Placebo-Controlled Study

M. Berman, M.D., A. Erman, Ph.D., T. Ben-Gal, M.D., D. Dvir, M.D., G. P. Georghiou, M.D., A. Stamler, M.D., Y. Vered, Ph.D., B. A. Vidne, M.D., D. Aravot, M.D. 295

Beneficial Effect of Candesartan Treatment on Cardiac Autonomic Nervous Activity in Patients with Chronic Heart Failure: Simultaneous Recording of Ambulatory Electrocardiogram and Posture

K. Tambara, M.D., M. Fujita, M.D., Y. Sumita, S. Miyamoto, M.D., H. Sekiguchi, Ph.D., S. Eiho, Ph.D., M. Komeda, M.D., Ph.D. 300

Images in Cardiology

Diagnosis of Pseudoaneurysm of the Aortic Arch with Transesophageal Echocardiogram

T. E. Hong, M.D., R. M. Lang, M.D. 270

Heterotopic Heart Transplantation

E. Leontiadis, M.D., A. Magninas, M.D., D. V. Cokkinos, M.D. 280

Progress in Clinical Trials
AMIHOT (Acute Myocardial Infarction with Hyperoxemic Therapy) 304
ARCHeR (Acculinkª for Revascularization of Carotids in High Risk Patients) 304
DINAMIT (Defibrillator IN Acute Myocardial Infarction Trial) 305
EMERALD (Enhanced Myocardial Efficacy and Removal by Aspiration of Liberated Debris) 305
PRAGUE-4 (PRimary angioplasty in AMI patients from General community hospitals transported to PCI Units versus Emergency thrombolysis) 305
PROVE-IT (Pravastatin or Atorvastatin Evaluation and Infection Therapy) 306
SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 306
SES-SMART (Sirolimus-Eluting and an Uncoated Stent in the Prevention of Restenosis in Small Coronary Arteries) 307
WATCH (The Warfarin and Antiplatelet Therapy in Chronic Heart Failure Trial) 307
Profiles in Cardiology

Meyer Friedman

A. B. Weisse, M.D., and G. W. Friedland, M.D. 308


©1997-2002 Foundation for Advances in Medicine and Science